Global Afrezza Exporter from India to Washington, USA, Zimbabwe & New Zealand
City Drug Exporters specializes in exporting Afrezza from India to international markets including Washington, USA, Zimbabwe, and New Zealand. We provide dependable supply solutions for pharmaceutical wholesalers, distributors, pharmacies, and healthcare procurement companies.
Afrezza is an ultra-rapid-acting inhaled human insulin indicated to improve glycemic control in children (6 years and older) and adults with diabetes mellitus . Delivered as a dry powder via a breath-activated inhaler, it acts quickly to manage mealtime blood sugar spikes and can be used for blood sugar corrections.
Therapeutic Uses :
Mealtime Glucose Control: Used to swiftly lower blood sugar spikes immediately following meals . It replaces or supplements the natural mealtime insulin that the body fails to produce or utilize efficiently.
Correction Doses: Can be used to correct high blood sugar levels outside of meals .
Type 1 and Type 2 Diabetes: Approved for patients 6 years of age and older . In Type 1 diabetes, it must be combined with long-acting (basal) insulin. In Type 2 diabetes, it can be used alongside basal insulin or other oral diabetes medications.
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
